- In January 2025, Siemens Healthineers announced the launch of its ADVIA Centaur XPT Immunoassay System in select European markets following CE mark approval. The system is designed to streamline laboratory workflow with enhanced automation, high throughput, and broad assay menu, including infectious diseases and cardiac biomarkers. Its advanced technology minimizes manual intervention and ensures reliable, rapid diagnostics, catering to mid- to high-volume clinical laboratories
- In November 2024, Abbott unveiled enhancements to its Alinity c clinical chemistry system at the Medica Trade Fair in Düsseldorf, Germany. The updated system features improved sample processing time and expanded reagent stability, allowing for faster turnaround and increased operational efficiency in diagnostic labs. These upgrades support laboratories in managing growing testing demands with greater accuracy and reliability
- In October 2024, F. Hoffmann-La Roche Ltd. showcased its next-generation cobas pro integrated solutions at the AACC Annual Scientific Meeting. The system integrates clinical chemistry and immunoassay testing into a single platform, offering high-speed processing and smart automation features to reduce hands-on time. Roche emphasized that this innovation is geared toward maximizing lab efficiency and addressing the global need for rapid, precise diagnostics
- In September 2024, Mindray introduced its latest BS-900M Modular System during the China International Medical Equipment Fair (CMEF). Designed for high-throughput laboratories, the system integrates clinical chemistry and immunoassay modules, offering scalable solutions, intuitive software, and real-time quality control. Mindray’s advancements aim to increase accessibility to robust diagnostics in both developed and emerging healthcare markets
